Evidence map›Paper›PMID 18840402›Full record

ArticleBiochemical and biophysical research communications2008

The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens.

Lang Tian, Hong-ning Wang, Dan Lu, Yun-fei Zhang, Ting Wang, Run-ming Kang

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Novel and emerging mutations of SARS-CoV-2: Biomedical implications.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lang TianCollege of Veterinary Medicine, Sichuan Agricultural University, Yaan, People's Republic of China.
Hong-ning Wang
Dan Lu
Yun-fei Zhang
Ting Wang
Run-ming Kang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epitope-based vaccines designed to induce cellular immune response and antibody responses specific for infectious bronchitis virus (IBV) are being developed as a means for increasing vaccine potency. In this study, we selected seven epitopes from the spike (S1), spike (S2), and nucleocapsid (N) protein and constructed a multi-epitope DNA vaccine. The 7-day-old chickens were immunized intramuscularly with multi-epitope DNA vaccine encapsulated by liposome and boosted two weeks later, and were challenged by virulent IBV strain five weeks post booster. The results showed that multi-epitope DNA vaccine led to a dramatic augmentation of humoral and cellular responses, and provided up to 80.0% rate of immune protection. The novel immunogenic chimeric multi-epitope DNA vaccine revealed in this study provided a new candidate target for IBV vaccine development.

Indexed as

AnimalsAntibody FormationChickensChlorocebus aethiopsCoronavirus Nucleocapsid ProteinsCOS CellsImmunity, CellularImmunodominant EpitopesInfectious bronchitis virusMembrane GlycoproteinsNucleocapsid ProteinsSpike Glycoprotein, CoronavirusVaccines, DNAViral Envelope ProteinsViral VaccinesCoronavirus Nucleocapsid ProteinsImmunodominant EpitopesMembrane GlycoproteinsNucleocapsid ProteinsSpike Glycoprotein, CoronavirusVaccines, DNAViral Envelope ProteinsViral Vaccines

Identifiers

PMID18840402
PMCPMC7117539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.